{"description":"At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":6,"description":"Ixazomib 4.0 mg, capsule, orally, once weekly on Days 1, 8 and 15 during each 28-day treatment cycle for 3 cycles. If there was no hematologic response, dexamethasone 40 mg, tablet, orally was added once on Days 1 to 4 of every cycle, beginning in Cycle 4 for 3 additional cycles. If there was no hematologic response the participant was discontinued. Participants with hematologic response continued treatment up to maximum 12 cycles.","id":"EG000","otherNumAffected":6,"otherNumAtRisk":6,"seriousNumAffected":3,"seriousNumAtRisk":6,"title":"Dose Escalation Cohort: Ixazomib 4.0 mg"},{"deathsNumAffected":0,"deathsNumAtRisk":5,"description":"Ixazomib 5.5 mg, capsule, orally, once weekly on Days 1, 8 and 15 during each 28-day treatment cycle for 3 cycles. If there was no hematologic response, dexamethasone 40 mg, tablet, orally was added once on Days 1 to 4 of every cycle, beginning in Cycle 4 for 3 additional cycles. If there was no hematologic response the participant was discontinued. Participants with hematologic response continued treatment up to maximum 12 cycles.","id":"EG001","otherNumAffected":5,"otherNumAtRisk":5,"seriousNumAffected":5,"seriousNumAtRisk":5,"title":"Dose Escalation Cohort: Ixazomib 5.5 mg"},{"deathsNumAffected":1,"deathsNumAtRisk":5,"description":"Ixazomib 4.0 mg, capsule, orally, on Days 1, 8 and 15 during a 28-day treatment cycle until progressive disease (PD) or unacceptable toxicity, for participants with relapsed or refractory amyloidosis and who were not treated with any other proteasome inhibitor (PI). Duration of treatment was up to 12 months unless the investigator and sponsor determined the participant would benefit from therapy beyond 12 months.","id":"EG002","otherNumAffected":5,"otherNumAtRisk":5,"seriousNumAffected":5,"seriousNumAtRisk":5,"title":"Dose Expansion Cohort: Ixazomib 4.0 mg (PI Naive)"},{"deathsNumAffected":0,"deathsNumAtRisk":11,"description":"Ixazomib 4.0 mg, capsule, orally, on Days 1, 8 and 15 during a 28-day treatment cycle until PD or unacceptable toxicity, for participants with relapsed or refractory amyloidosis and who were previously treated with any other PI. Duration of treatment was up to 12 months unless the investigator and sponsor determined the participant would benefit from therapy beyond 12 months.","id":"EG003","otherNumAffected":10,"otherNumAtRisk":11,"seriousNumAffected":5,"seriousNumAtRisk":11,"title":"Dose Expansion Cohort: Ixazomib 4.0 mg (PI Exposed)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":6},{"groupId":"EG001","numAffected":4,"numAtRisk":5},{"groupId":"EG002","numAffected":3,"numAtRisk":5},{"groupId":"EG003","numAffected":4,"numAtRisk":11}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6},{"groupId":"EG001","numAffected":3,"numAtRisk":5},{"groupId":"EG002","numAffected":3,"numAtRisk":5},{"groupId":"EG003","numAffected":5,"numAtRisk":11}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6},{"groupId":"EG001","numAffected":3,"numAtRisk":5},{"groupId":"EG002","numAffected":3,"numAtRisk":5},{"groupId":"EG003","numAffected":6,"numAtRisk":11}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":3,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":3,"numAtRisk":11}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":3,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":5,"numAtRisk":11}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":3,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":5,"numAtRisk":11}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":3,"numAtRisk":11}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":3,"numAtRisk":11}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":3,"numAtRisk":11}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":3,"numAtRisk":11}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Contusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Dysgeusia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Cardiac failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Fall"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Fluid retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Increased tendency to bruise"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Nasal congestion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Neuropathy peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Abdominal distension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Abdominal pain upper"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Angina pectoris"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Atrial flutter"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Conjunctivitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Dry eye"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Dry mouth"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Gait disturbance"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Influenza like illness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Mood altered"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":2,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Ocular hyperaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Rash macular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":2,"numAtRisk":11}],"term":"Rash pruritic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Skin lesion"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":2,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"One treatment-emergent death occurred during treatment with Dose Expansion Cohort: Ixazomib 4 mg (PI Naive) and is not related.","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Cardiac failure congestive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Angina pectoris"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Cardiac arrest"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Cardiac failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Cholecystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Facial pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Fall"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Haemothorax"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hyperkalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Hypoxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Plasmacytoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Presyncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":1,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":1,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Squamous cell carcinoma of skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":1,"numAtRisk":11}],"term":"Influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6},{"groupId":"EG001","numAffected":0,"numAtRisk":5},{"groupId":"EG002","numAffected":0,"numAtRisk":5},{"groupId":"EG003","numAffected":0,"numAtRisk":11}],"term":"Nausea"}],"timeFrame":"From the first dose of study drug plus 30 days after last dose of study drug or until the initiation of subsequent antineoplastic therapy (Up to approximately 13 months)"}